Genedant
VC Fund
Genedant is a VC fund focused on Biotechnology and Food and Beverage. Genedant invests in emerging life science and technology which challenge the conventional thinking of what is possible.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Genedant invests in
Stages Genedant invests in
Countries Genedant invests in
Investment Focus
Industry
- Biotechnology 2 (29%)
- Food and Beverage 2 (29%)
- Beauty 1 (14%)
- Medical 1 (14%)
- Health Care 1 (14%)
Stage
- Seed 4 (57%)
- Pre-Seed 2 (29%)
- Series A 1 (14%)
Country
- Singapore 2 (29%)
- Australia 1 (14%)
- United States 1 (14%)
- United Kingdom 1 (14%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Rybodyn
|
Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally. | $10M / Seed / Mar 24, 2026 | |
|
Rybodyn
|
Rybodyn is a biotechnology research company that develops therapeutics to train the immune system to detect and eradicate cancer internally. | $4M / Pre-Seed / Jan 09, 2025 | |
Auristone
|
Auristone Providing actionable clinical insights with our epigenomics based workflows and actionable epigenomic information and analyses from proprietary pipelines and predictive models. | $4M / Seed / Apr 02, 2024 | |
Fable Food
|
Fable Food Co is a meat alternative company known for its meaty food made from mushrooms, which are clean label, minimally processed and made with all natural plant-based ingredients. The products are available in Harris Farm Markets, Coles and Woolworths, as well as Marley Spoon and Dinnerly meal delivery kits, and in various restaurant menusaround Australia, Singapore, and the UK. | $8.6M / Series A / Feb 08, 2023 | |
UMAMI Bioworks
|
Umami Meats is developing delicious, affordable, sustainable cell-cultured seafood based on a proprietary, low-cost growth serum and novel marine cell lines. | $2.4M / Seed / Mar 02, 2022 | |
|
UMAMI Bioworks
|
Umami Meats is developing delicious, affordable, sustainable cell-cultured seafood based on a proprietary, low-cost growth serum and novel marine cell lines. | $2.4M / Pre-Seed / Mar 02, 2022 | |
SEQUENTIAL
|
Sequential Skin and Sequential Bio fall under the umbrella of Sequential: The Skin Microbiome Testing Co™Awarded the title "Most Significant" Testing Solution in the Industry - (Cosmetics & Toiletries, 2022), Sequential Bio is the skin microbiome company of the industry that specializes in microbiome testing and claimssubstantiation for brands formulating products for skin, scalp, vagina/vulva and oral care. Sequential offers a full end-to-end platform from study design, recruitment and testing, to analysis, and support on formulation development and certification. And it’s all done in vivo!Sequential Skin on the other hand is revolutionising skin health with the world's first consumer skin microbiome test. Formed of an award-winning team with a mission to empower individuals to make better-informed decisions about their skin health. (www.sequentialskin.com)Sequential is the product of the team's combined expertise in epigenetics, genetics, and microbiome research. Supported by Innovate UK, Enterprise SG, A*STAR, Genome Institute of Singapore, IndieBio New York, SOSV, Metaplanet, Scrum Ventures, CSB, and is a resident company of Johnson & Johnson Innovation – JLABS.Seen in Tatler, Cosmetic Designs, Tech Crunch, Genome Web, La Petite Journal, Global Wellness Summit, and Yahoo. | $1.7M / Seed / Oct 10, 2021 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Genedant invest in?
Genedant invests primarily in Biotechnology, Food and Beverage and Beauty startups, most often at Seed and Pre-Seed stage. Most of the 7 investments tracked by Shizune back companies in Singapore. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Genedant last invest?
The most recent investment recorded for Genedant closed in Mar 2026. Shizune tracks 7 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
